Clinical trial
A Study to Determine the Absorption, Distribution, Metabolism, and Excretion of…
NCT00472368 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00472368 |
|---|---|
| Title | A Study to Determine the Absorption, Distribution, Metabolism, and Excretion of LBH589 |
| Official title | An Open-label, Single Center, Study to Determine the Absorption, Distribution, Metabolism, and Excretion (ADME) of LBH589 After a Single Oral Administration of 20 mg (14C) LBH589 in Advanced Cancer Patients |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological Malignancies |
| Intervention type | Drug |
| Interventions | LBH589 |
| Enrollment | 4 |
| Start date | May 1, 2007 |
| Primary completion | Jun 1, 2008 |
| First posted | May 11, 2007 |
| Last update posted | May 1, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: